BEAM
Price
$17.14
Change
+$0.26 (+1.54%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
1.72B
69 days until earnings call
CCCC
Price
$1.52
Change
+$0.04 (+2.70%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
109.35M
63 days until earnings call
Interact to see
Advertisement

BEAM vs CCCC

Header iconBEAM vs CCCC Comparison
Open Charts BEAM vs CCCCBanner chart's image
Beam Therapeutics
Price$17.14
Change+$0.26 (+1.54%)
Volume$17.78K
Capitalization1.72B
C4 Therapeutics
Price$1.52
Change+$0.04 (+2.70%)
Volume$5.54K
Capitalization109.35M
BEAM vs CCCC Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CCCC commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (BEAM: $17.15 vs. CCCC: $1.48)
Brand notoriety: BEAM and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 56% vs. CCCC: 100%
Market capitalization -- BEAM: $1.72B vs. CCCC: $105.09M
BEAM [@Biotechnology] is valued at $1.72B. CCCC’s [@Biotechnology] market capitalization is $105.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and CCCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while CCCC’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 4 bearish.
  • CCCC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +0.70% price change this week, while CCCC (@Biotechnology) price change was +13.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CCCC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.73B) has a higher market cap than CCCC($109M). BEAM YTD gains are higher at: -30.847 vs. CCCC (-58.889). CCCC has higher annual earnings (EBITDA): -102.74M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CCCC (215M). CCCC has less debt than BEAM: CCCC (64.4M) vs BEAM (158M). BEAM has higher revenues than CCCC: BEAM (63.6M) vs CCCC (39.8M).
BEAMCCCCBEAM / CCCC
Capitalization1.73B109M1,583%
EBITDA-399.03M-102.74M388%
Gain YTD-30.847-58.88952%
P/E RatioN/AN/A-
Revenue63.6M39.8M160%
Total Cash1.22B215M567%
Total Debt158M64.4M245%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCCCC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDRX4.30N/A
N/A
Veradigm Inc.
SHTDY12.12N/A
-0.04%
Sinopharm Group Co. Ltd.
PPRUY19.57-0.08
-0.41%
Kering SA
HKHHY38.99-0.40
-1.01%
Heineken Holding N.V.
DSHK0.11N/A
-2.27%
Drive Shack Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+11.28%
KYMR - CCCC
59%
Loosely correlated
+1.04%
CRBU - CCCC
54%
Loosely correlated
+7.70%
BEAM - CCCC
54%
Loosely correlated
+4.26%
FATE - CCCC
53%
Loosely correlated
+4.62%
IMNM - CCCC
51%
Loosely correlated
+2.21%
More